针对乳腺癌的关键信号通路:从分子机制到治疗干预
1Department of Pharmaceutical Sciences, Shalom Institute of Health and Allied Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj-211008, India.
Recent patents on anti-cancer drug discovery
|January 22, 2024
概括
乳腺癌干细胞 (BCSCs) 驱动瘤的生长和复发. 了解它们的信号通路和瘤微环境相互作用是开发新型乳腺癌治疗方法和识别不响应患者的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 乳腺癌仍然是一个重大的全球健康问题.
- 乳腺癌干细胞 (BCSCs) 对于瘤发病,复发和转移至关重要.
- 基因表达在BCSC中是复杂的,受到细胞外线索,突变和表观遗传因素的影响.
研究的目的:
- 探索涉及乳腺癌干细胞生物学中的内在和外在分子通路.
- 为了确定潜在的治疗干预的新信号通路.
- 突出研究确定患有不响应标准治疗风险的患者的研究.
主要方法:
- 审查关于乳腺癌干细胞和信号通路的当前文献.
- 分析瘤微环境对BCSCs的影响.
- 检查专利的信号通路向分子及其临床应用.
主要成果:
- 在BCSC中涉及的关键信号通路包括,NOTCH,STAT3,Wnt/β-catenin和NF-κB.
- 瘤微环境,特别是缺氧,会影响BCSC的行为.
- PARP 抑制剂在乳腺癌治疗中表现有前途.
结论:
- 了解BCSC信号和微环境相互作用对于推进乳腺癌治疗至关重要.
- 针对这些途径的新型治疗策略可以改善治疗结果.
- 对分子通路的进一步研究可以有助于针对乳腺癌的个性化医疗方法.
相关概念视频
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Canonical Wnt Signaling Pathway
8.8K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K


